A portfolio with profound benefits for patients and doctors
Our first focus is on diseases associated with neuro-inflammation with a particular focus on Age-related Macular Degeneration (AMD) and Post-Traumatic Epilepsy (PTE).
Working with global partners to take Australian innovation to the world
Our highly capable expert team has significant experience in the development and commercialisation of biological therapies
Ian Nisbet PhD
Tel: +61 (0)431 709 121